Skip to main content
INOVIO PHARMACEUTICALS, INC. logo

INOVIO PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · INO ISIN · US45773H4092 LEI · 529900B9W875XDZXTM97 US Manufacturing
Open in API
Filings indexed 1,003 across all filing types
Latest filing 2026-05-22 Share Issue/Capital Cha…
Country US United States of America
Listing US INO

About INOVIO PHARMACEUTICALS, INC.

https://www.inovio.com/

INOVIO PHARMACEUTICALS, INC. is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines. The company's core technology centers on designing proprietary DNA plasmids—small, circular DNA molecules that instruct the body's cells to produce specific, targeted proteins to combat disease. These DNA medicines are delivered into cells using the company's proprietary investigational CELLECTRA® smart devices. This platform is designed to enable in vivo protein production and achieve therapeutic effect without the use of chemical adjuvants, lipid nanoparticles, or viral vectors. The company's development pipeline targets HPV-related diseases, various cancers, and infectious diseases.

Recent filings

Filing Released Lang Actions
S-8
Share Issue/Capital Change Classification · 90% confidence The document is a full SEC Form S-8 registration statement under the Securities Act of 1933, registering 10,200,000 shares of common stock to be issued pursuant to an amended and restated omnibus incentive plan. This is a direct registration of new shares and thus constitutes a capital change/share issuance, matching the definition of Share Issue/Capital Change (SHA). It is not merely an announcement or summary, but the actual registration filing itself.
2026-05-22 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a Form 8-K current report disclosing (1) an amendment to the company’s bylaws and (2) the detailed vote tabulation for proposals at the 2026 Annual Meeting of Stockholders (listing “For,” “Against,” “Abstain,” and “Broker Non-Votes” for each proposal). The inclusion of official shareholder vote results at a general meeting directly aligns with the Definition of “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2026-05-20 English
10-Q - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
8-K - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC by Inovio Pharmaceuticals, Inc. dated April 2, 2026. It reports the entry into a material definitive agreement related to a public offering of common stock and warrants, including details about the underwriting agreement, terms of the offering, and related exhibits. The document is a current report disclosing a capital raising event and financing activity. It is not an annual or quarterly report, audit report, earnings release, or other types of filings. The content clearly fits the category of Capital/Financing Update as it provides detailed information about a new financing transaction and related agreements.
2026-04-06 English
8-K - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 1, 2026. It reports the suspension and termination of a prospectus related to an 'at-the-market' sales agreement for common stock. The document does not contain financial statements or detailed financial analysis but rather announces a capital market activity update regarding the sales agreement and stock issuance. The length is 3603 characters, which is relatively short and focused on a specific event. This fits the category of Capital/Financing Update (CAP), as it relates to fundraising activities and capital structure changes through the sales agreement and stock sales.
2026-04-02 English
4 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)
Director's Dealing
2026-02-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.